Stephen Saad (52)

Aspen Group Chief Executive

Qualifications: CA(SA)

Appointed: January 1999

Stephen is a founding shareholder of the Aspen Group and his responsibilities extend to include the strategic positioning and global transactions, geographic expansion and product diversification of Aspen in developed and emerging markets as a leading multinational pharmaceutical company.

Gus Attridge (55)

Executive director; Deputy Group Chief Executive

Qualifications: CA(SA)

Appointed: January 1999

A founder of Aspen, Gus is the Deputy Group Chief Executive of the Aspen Group. He is also a member of the Social & Ethics Committee and attends meetings of all of the other Board Committees by invitation.

Kuseni Dlamini (48)

Independant Non-Executive, Chairman designate

Qualifications: MPhil (Oxon), BSocSci (Hons), (Natal) Global Leadershi[ for the 21st Century Programme (Harvard) Foundations for Leadershi[ in the 21st Century (Yale)

Appointed: April 2012

Kuseni is the Chairman of Massmart Holdings Limited. He was previously Chairman of Times Media Group Limited and Chief Executive Officer of Old Mutual South Africa and Emerging Markets. He brings a wealth of economic and business skills to the board having previously held positions as the Head of Anglo American South Africa and Executive Chairman of Richards Bay Coal Terminal Company. Kuseni is the former Chairman of the South African National Parks (SANParks) and a former member of the Global Agenda Council on Economic Growth and Poverty Alleviation formed by the World Economic Forum. He is active in academic and professional bodies which include the Council of the University of Pretoria, South African Institute of International Affairs (SAIIA) and the advisory boards of the Gordon Institute of Business Science and Common Purpose. Kuseni is a member of the Remuneration & Nomination Committee.

Chris Mortimer (55)

Non-executive

Qualifications: BA, LLB

Appointed: January 1999

Chris has been a full-time practising attorney since 1988 and has substantial legal and commercial expertise. His intimate knowledge of the Group, its business operations and governance processes has been of immense benefit to Aspen over the years and he continues to serve the Board as a trusted adviser. As Chris’ firm is intermittently called upon to provide legal advice to the Group, he is classified as a non-independent executive director.

Babalwa Ngonyama (42)

Independant Non-executive

Qualifications: CA (SA), MBA

Appointed: April 2016

Babalwa was appointed to the Board on 1 April 2016 and is the CEO of Sinayo Securities (Pty) Limited, a women owned and managed securities firm. Prior to this she was the Group Chief Internal Auditor of Nedbank Limited, the past Financial Director of Safika Holdings, an audit partner at Nkonki Chartered Accountants and, thereafter, a partner at Deloitte (Financial Institutions Services Team). She is, among others, a non-executive director and member of the audit committees of Barloworld Limited, Implats Limited and Group Five Limited and brings considerable financial and commercial experience to the Board. Babalwa is the founding chairman of the African Women Chartered Accountants. Babalwa is a member of the Audit & Risk Committee.

David Redfern (50)

Non-executive

Qualifications: BSc (Hons), CA

Appointed: February 2015

David was appointed Chief Strategy Officer of GSK in May 2008 and is responsible for corporate development and strategic planning. During the last six years GSK has entered into numerous bolt-on acquisitions and joint ventures including, in particular, a multi-billion dollar three-way asset swap with Novartis. He is a member of the Corporate Executive Team and reports to the CEO, Sir Andrew Witty. Previously, he was responsible for the leadership of GSK’s business in Northern Europe from 2005 to 2008 and Central and Eastern Europe from 2002 to 2005. He joined Glaxo in 1994 in finance and progressed through a series of finance roles before becoming Finance Director of the European business in 1999. In addition to his current role, David is Chairman of ViiV Healthcare Limited. ViiV is a joint venture between GSK, Pfizer and Shionogi and focuses specifically on the development and commercialisation of medicines to treat HIV.

Roy Andersen (68)

Lead independent non-executive

Qualifications: CA(SA), CPA (Texas), CD (SA)

Appointed: August 2008

A Chartered Accountant by profession and with significant experience in the banking, insurance, construction and packaging industries, Roy’s expertise in fields such as governance and remuneration have been of great benefit to Aspen. He was previously Chairman and Chief Executive of Ernst & Young, Chief Executive of the Liberty Group Limited and a former President of JSE Limited. Roy is currently a non-executive director of Nampak Limited, Chairman of SASFIN Limited and SASFIN Bank Limited and a Major General in the South African National Defence Force, holding the post of Chief of Defence Reserves. He is a member of the King Committee on Corporate Governance. Roy serves as lead independent non-executive director and is the Chairman of the Remuneration & Nomination Committee and a member of the Audit & Risk Committee.

John Buchanan (72)

Independent non-executive

Qualifications: CA(SA), BTh (Hons) EDP (Columbia)

Appointed: May 2002

John brings vast financial and business management experience to the Board having held a number of executive positions with leading South African companies. He was previously the Group Finance Director of Cadbury Schweppes (South Africa) Limited and Metal Box (South Africa) Limited, as well as a past executive director of Nampak Limited. He has also served as a non-executive director on the boards of companies in the ICT and packaging industries, where he was Chairman of their Audit and Risk committees. He currently serves on the National Council of the South African Institute of International Affairs and is chairman of its Finance Committee. In addition to his non-executive directorship of Aspen, he chairs the Audit & Risk Committee and is a member of the Remuneration & Nomination Committee.

Maureen Manyama (39)

Independent non-executive

Qualifications: CA(SA), BCom Honours (Taxation), MBA

Appointed: June 2014

Maureen has 14 years combined experience in the various fields on a governance level. She started her career in external auditing, followed by internal audit financial reporting and management while qualifying as a Chartered Accountant. Maureen is currently Chief Financial Officer and executive director of the Airports Company of South Africa Limited. Prior to this role, she was Chief Financial Officer of the South African Forestry Company Limited. She is a non-executive director of the South African Reserve Bank and serves on this bank’s Audit Committee. She has also held directorships on a number of other boards during the past nine years. Maureen is a member of the Audit & Risk Committee.

Sindi Zilwa (49)

Independent non-executive

Qualifications: CA(SA), CDSA, Advanced Taxation (UNISA) Certificate, Advanced Diploma in Planning (UOFS) and Advanced Diploma in Banking (RAU)

Appointed: September 2006

Sindi, a Chartered Accountant by profession, is an expert in the areas of accounting, auditing and business management. She is currently the Chief Executive Officer of Nkonki Incorporated. Sindi is a Chartered Director (SA) and has had vast experience as a director in the public and private sectors and currently serves as a non-executive director of Discovery Holdings Limited, Metrofile Limited and Gijimi Limited. She is an author of “The ACE Model-Winning Formula for Audit Committees”, used by the Institute of Directors to train audit committee members in South Africa. Her second book, “Creating Board and Committee Effectiveness” has recently been published by KR Publishing. She is a member of the South African Institute of Chartered Accountants and Independent Regulatory Board for Auditors. Sindi was previously Non-Executive Chairman of Airports Company South Africa and a non-executive director of Woolworths Limited, Primedia Limited, Wiphold Limited, Ethos Private Equity, Institute of Directors, Alexkor Limited, Rebosis Limited, ATNS SOC Limited and previously chaired the BUSA Standing Committee on Transformation. Among her awards is the “Business Woman of the Year Award”, Sindi won in 1998. In 2008 she was named the “Woman of substance” by AWCA and in 2014 she received the “Woman of Professional Integrity Award” from the South African Professional Services Awards. Sindi serves as chairman of the Social & Ethics Committee and is a member of the Audit & Risk Committee.